CCL4 and hepatitis A virus infection: Although the evidence concerning the role of MIP1b in COVID-19 is inevitably limited, MIP1b has been extensively investigated in other viral diseases, such as HIV (Cocchi et al., 2000) and hepatitis A (Sung et al., 2017).